Ms. Jjingo regularly advises a variety of financial institutions, including Bank of America, Barclays, Citibank, Credit Suisse, Goldman Sachs, HSBC, ING and Morgan Stanley. She was recognized as a Rising Star in IFLR1000, as well as a Rising Star in Finance at Euromoney Legal Media Group’s 2019 Americas Women in Business Law Awards and as a Rising Star Best in Banking & Finance at Euromoney Legal Media Group’s 2019 Americas Rising Star Awards.
Her representations have included:
- York Capital Management in its sale of The Bay Club Company to KKR & Co. Inc.;
- Visteon Corporation in various amendments to its credit agreement including the replacement and repricing of the existing term facility with a new $350 million term loan facility; and in the $3.6 billion sale of its 70 percent stake in Halla Visteon Climate Control Corp. (South Korea);
- Key Safety Systems, Inc. in its $1.6 billion acquisition of substantially all of the assets and operations of Takata Corporation (Japan), as part of Takata’s Chapter 11 case;
- BlackRock, Inc. in a variety of matters involving revolving credit facilities and its $20 billion acquisition of Barclays Global Investors;
- Synergy Pharmaceuticals in its Chapter 11 filing, DIP financing and sale of substantially all of its assets to Bausch Health;
- Pinnacle Entertainment, Inc. in its $2.8 billion acquisition by Penn National Gaming, Inc.;
- DST Systems, Inc. in its $5.4 billion acquisition by SS&C Technologies Holdings, Inc.;
- Permira Funds in connection with a first lien $325 million term loan and $50 million revolving facility, in addition to a second lien $120 million term loan to finance its acquisition of DiversiTech Holdings, Inc.;
- Gilead in a variety of matters, including its $11.9 billion acquisition of Kite Pharma, Inc. and its $11 billion acquisition for Pharmasset, Inc.;
- Valeant Pharmaceuticals International, Inc. in its:
- $2.6 billion acquisition of Medicis Pharmaceutical Corporation;
- $800 million acquisition of Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical Company S.A.E. (Egypt); and
- its $15 billion acquisition of Salix Pharmaceuticals Ltd.;
- A&E Television Networks in connection with the financing of NBCUniversal Media, LLC’s $3 billion sale of its 15.8 percent stake in A&E to The Walt Disney Corporation and Hearst Corporation; and
- E.I. DuPont de Nemours and Company in its:
- $7.4 billion acquisition of Danisco A/S, a manufacturer of food ingredients; and
- in a $3.5 billion revolving credit facility from JPMorgan Chase Bank, N.A.